Which program is a population-based cancer registry funded by the National Cancer Institute and provides longitudinal data on stage at diagnosis and survival?

Which program is a population-based cancer registry funded by the National Cancer Institute and provides longitudinal data on stage at diagnosis and survival?

• A. National Cancer Registrars Association
• B. American Cancer Society
• C. National Program of Cancer Registries
• D. Surveillance, Epidemiology, and End Results (SEER)

Answer: (D)

This question focuses on a population-based cancer registry that is supported by the National Cancer Institute and tracks patients over time to capture both the stage at diagnosis and survival outcomes. The program that fits this description is SEER—the Surveillance, Epidemiology, and End Results program. SEER collects incidence data from population-based registries across selected geographic areas, and it links patients over time to record vital status and survival. It also gathers detailed tumor characteristics, including stage at diagnosis, allowing researchers to analyze survival by stage, site, patient demographics, and other factors. This longitudinal survival data is a hallmark of SEER and what sets it apart from other registries. The National Program of Cancer Registries, while also population-based and essential for comprehensive cancer incidence data in the U.S., is funded by the CDC and does not center on providing longitudinal survival data in the same integrated way as SEER. The National Cancer Registrars Association is a professional organization, not a data registry program, and the American Cancer Society, while a major cancer-focused nonprofit, is not a population-based registry program.

This question focuses on a population-based cancer registry that is supported by the National Cancer Institute and tracks patients over time to capture both the stage at diagnosis and survival outcomes. The program that fits this description is SEER—the Surveillance, Epidemiology, and End Results program. SEER collects incidence data from population-based registries across selected geographic areas, and it links patients over time to record vital status and survival. It also gathers detailed tumor characteristics, including stage at diagnosis, allowing researchers to analyze survival by stage, site, patient demographics, and other factors. This longitudinal survival data is a hallmark of SEER and what sets it apart from other registries.

The National Program of Cancer Registries, while also population-based and essential for comprehensive cancer incidence data in the U.S., is funded by the CDC and does not center on providing longitudinal survival data in the same integrated way as SEER. The National Cancer Registrars Association is a professional organization, not a data registry program, and the American Cancer Society, while a major cancer-focused nonprofit, is not a population-based registry program.